{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:15:28Z","timestamp":1792156528427,"version":"4.4.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"DOI":"10.1038\/s41551-021-00827-5","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T12:03:00Z","timestamp":1641470580000},"page":"389-402","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Conditional immortalization of human atrial myocytes for the generation of in vitro models of atrial fibrillation"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2790-8708","authenticated-orcid":false,"given":"Niels","family":"Harlaar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven O.","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8053-1191","authenticated-orcid":false,"given":"Rebecca R.","family":"Snabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke W.","family":"Veldkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2140-834X","authenticated-orcid":false,"given":"Arie O.","family":"Verkerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Cofi\u00f1o","family":"Fabres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Schwach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lente J. S.","family":"Lerink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde R.","family":"Rivaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aat A.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem E.","family":"Corver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9344-6746","authenticated-orcid":false,"given":"Marie Jos\u00e9 T. H.","family":"Goumans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dobromir","family":"Dobrev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J. M.","family":"Klautz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Schalij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7787-4940","authenticated-orcid":false,"given":"Gert Jan C.","family":"Veenstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4312-9296","authenticated-orcid":false,"given":"Robert","family":"Passier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"van Brakel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00ebl A.","family":"Pijnappels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4787-7155","authenticated-orcid":false,"given":"Antoine A. F.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,6]]},"reference":[{"key":"827_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijsu.2019.10.015","volume":"72","author":"NB Robinson","year":"2019","unstructured":"Robinson, N. B. et al. The current state of animal models in research: a review. Int. J. Surg. 72, 9\u201313 (2019).","journal-title":"Int. J. Surg."},{"key":"827_CR2","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1080\/15384101.2015.1120925","volume":"15","author":"S Ruijtenberg","year":"2016","unstructured":"Ruijtenberg, S. & van den Heuvel, S. Coordinating cell proliferation and differentiation: antagonism between cell cycle regulators and cell type-specific gene expression. Cell Cycle 15, 196\u2013212 (2016).","journal-title":"Cell Cycle"},{"key":"827_CR3","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","volume":"282","author":"JA Thomson","year":"1998","unstructured":"Thomson, J. A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145\u20131147 (1998).","journal-title":"Science"},{"key":"827_CR4","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861\u2013872 (2007).","journal-title":"Cell"},{"key":"827_CR5","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917\u20131920 (2007).","journal-title":"Science"},{"key":"827_CR6","doi-asserted-by":"publisher","unstructured":"Kim, J., Koo, B. K. & Knoblich, J. A. Human organoids: model systems for human biology and medicine. Nat. Rev. Mol. Cell Biol. https:\/\/doi.org\/10.1038\/s41580-020-0259-3 (2020).","DOI":"10.1038\/s41580-020-0259-3"},{"key":"827_CR7","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1093\/cvr\/cvy134","volume":"114","author":"J Liu","year":"2018","unstructured":"Liu, J. et al. Generation and primary characterization of iAM-1, a versatile new line of conditionally immortalized atrial myocytes with preserved cardiomyogenic differentiation capacity. Cardiovasc. Res. 114, 1848\u20131859 (2018).","journal-title":"Cardiovasc. Res."},{"key":"827_CR8","doi-asserted-by":"publisher","first-page":"158511","DOI":"10.1016\/j.bbalip.2019.08.007","volume":"1864","author":"J Liu","year":"2019","unstructured":"Liu, J. et al. Conditionally immortalized brown preadipocytes can switch between proliferative and differentiated states. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1864, 158511 (2019).","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"827_CR9","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1128\/MCB.15.4.1907","volume":"15","author":"U Deuschle","year":"1995","unstructured":"Deuschle, U., Meyer, W. K. & Thiesen, H. J. Tetracycline-reversible silencing of eukaryotic promoters. Mol. Cell. Biol. 15, 1907\u20131914 (1995).","journal-title":"Mol. Cell. Biol."},{"key":"827_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nmeth846","volume":"3","author":"J Szulc","year":"2006","unstructured":"Szulc, J., Wiznerowicz, M., Sauvain, M. O., Trono, D. & Aebischer, P. A versatile tool for conditional gene expression and knockdown. Nat. Methods 3, 109\u2013116 (2006).","journal-title":"Nat. Methods"},{"key":"827_CR11","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","volume":"129","author":"SS Chugh","year":"2014","unstructured":"Chugh, S. S. et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 129, 837\u2013847 (2014).","journal-title":"Circulation"},{"key":"827_CR12","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1161\/CIRCOUTCOMES.110.958165","volume":"4","author":"MH Kim","year":"2011","unstructured":"Kim, M. H., Johnston, S. S., Chu, B. C., Dalal, M. R. & Schulman, K. L. Estimation of total incremental health care costs in patients with atrial fibrillation in the United States. Circ. Cardiovasc. Qual. Outcomes 4, 313\u2013320 (2011).","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"827_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1161\/CIRCRESAHA.120.316363","volume":"127","author":"S Nattel","year":"2020","unstructured":"Nattel, S., Heijman, J., Zhou, L. & Dobrev, D. Molecular basis of atrial fibrillation pathophysiology and therapy: a translational perspective. Circ. Res. 127, 51\u201372 (2020).","journal-title":"Circ. Res."},{"key":"827_CR14","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1161\/CIRCRESAHA.117.311081","volume":"122","author":"J Heijman","year":"2018","unstructured":"Heijman, J., Guichard, J. B., Dobrev, D. & Nattel, S. Translational challenges in atrial fibrillation. Circ. Res. 122, 752\u2013773 (2018).","journal-title":"Circ. Res."},{"key":"827_CR15","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1016\/S0140-6736(17)31072-3","volume":"390","author":"P Kirchhof","year":"2017","unstructured":"Kirchhof, P. The future of atrial fibrillation management: integrated care and stratified therapy. Lancet 390, 1873\u20131887 (2017).","journal-title":"Lancet"},{"key":"827_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fcvm.2020.00043","volume":"7","author":"PRR van Gorp","year":"2020","unstructured":"van Gorp, P. R. R., Trines, S. A., Pijnappels, D. A. & de Vries, A. A. F. Multicellular in vitro models of cardiac arrhythmias: focus on atrial fibrillation. Front. Cardiovasc. Med. 7, 43 (2020).","journal-title":"Front. Cardiovasc. Med."},{"key":"827_CR17","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/sj.mt.6300027","volume":"15","author":"MZ Salva","year":"2007","unstructured":"Salva, M. Z. et al. Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle. Mol. Ther. 15, 320\u2013329 (2007).","journal-title":"Mol. Ther."},{"key":"827_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1054-8807(01)00065-5","volume":"10","author":"Y Huttenbach","year":"2001","unstructured":"Huttenbach, Y., Ostrowski, M. L., Thaller, D. & Kim, H. S. Cell proliferation in the growing human heart: MIB-1 immunostaining in preterm and term infants at autopsy. Cardiovasc. Pathol. 10, 119\u2013123 (2001).","journal-title":"Cardiovasc. Pathol."},{"key":"827_CR19","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1016\/j.celrep.2019.01.079","volume":"26","author":"Y Cui","year":"2019","unstructured":"Cui, Y. et al. Single-cell transcriptome analysis maps the developmental track of the human heart. Cell Rep. 26, 1934\u20131950.e5 (2019).","journal-title":"Cell Rep."},{"key":"827_CR20","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"GT Consortium","year":"2013","unstructured":"Consortium, G. T. The genotype-tissue expression (GTEx) project. Nat. Genet. 45, 580\u2013585 (2013).","journal-title":"Nat. Genet."},{"key":"827_CR21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/537433a","volume":"537","author":"M Baker","year":"2016","unstructured":"Baker, M. Reproducibility: respect your cells! Nature 537, 433\u2013435 (2016).","journal-title":"Nature"},{"key":"827_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1161\/CIRCEP.111.977264","volume":"6","author":"SM Narayan","year":"2013","unstructured":"Narayan, S. M., Shivkumar, K., Krummen, D. E., Miller, J. M. & Rappel, W. J. Panoramic electrophysiological mapping but not electrogram morphology identifies stable sources for human atrial fibrillation: stable atrial fibrillation rotors and focal sources relate poorly to fractionated electrograms. Circ. Arrhythm. Electrophysiol. 6, 58\u201367 (2013).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"827_CR23","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/clc.22674","volume":"40","author":"M Balouch","year":"2017","unstructured":"Balouch, M. et al. Impact of rotor temperospatial stability on acute and one-year atrial fibrillation ablation outcomes. Clin. Cardiol. 40, 383\u2013389 (2017).","journal-title":"Clin. Cardiol."},{"key":"827_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05652-y","volume":"7","author":"Z Laksman","year":"2017","unstructured":"Laksman, Z. et al. Modeling atrial fibrillation using human embryonic stem cell-derived atrial tissue. Sci. Rep. 7, 5268 (2017).","journal-title":"Sci. Rep."},{"key":"827_CR25","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1161\/CIRCULATIONAHA.104.517011","volume":"112","author":"P Sanders","year":"2005","unstructured":"Sanders, P. et al. Spectral analysis identifies sites of high-frequency activity maintaining atrial fibrillation in humans. Circulation 112, 789\u2013797 (2005).","journal-title":"Circulation"},{"key":"827_CR26","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.jelectrocard.2006.04.009","volume":"39","author":"RB Schuessler","year":"2006","unstructured":"Schuessler, R. B. et al. Spatial and temporal stability of the dominant frequency of activation in human atrial fibrillation. J. Electrocardiol. 39, S7\u2013S12 (2006).","journal-title":"J. Electrocardiol."},{"key":"827_CR27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.hrthm.2010.10.030","volume":"8","author":"K Yoshida","year":"2011","unstructured":"Yoshida, K. et al. Left atrial pressure and dominant frequency of atrial fibrillation in humans. Heart Rhythm 8, 181\u2013187 (2011).","journal-title":"Heart Rhythm"},{"key":"827_CR28","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","volume":"64","author":"CT January","year":"2014","unstructured":"January, C. T. et al. 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J. Am. Coll. Cardiol. 64, e1\u2013e76 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"827_CR29","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof, P. et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur. Heart J. 37, 2893\u20132962 (2016).","journal-title":"Eur. Heart J."},{"key":"827_CR30","doi-asserted-by":"publisher","unstructured":"Hindricks, G. et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur. Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612 (2020).","DOI":"10.1093\/eurheartj\/ehaa612"},{"key":"827_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1085\/jgp.96.1.195","volume":"96","author":"MC Sanguinetti","year":"1990","unstructured":"Sanguinetti, M. C. & Jurkiewicz, N. K. Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents. J. Gen. Physiol. 96, 195\u2013215 (1990).","journal-title":"J. Gen. Physiol."},{"key":"827_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.yjmcc.2015.06.021","volume":"86","author":"D Melgari","year":"2015","unstructured":"Melgari, D., Zhang, Y., El Harchi, A., Dempsey, C. E. & Hancox, J. C. Molecular basis of hERG potassium channel blockade by the class Ic antiarrhythmic flecainide. J. Mol. Cell. Cardiol. 86, 42\u201353 (2015).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"827_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.yjmcc.2005.03.003","volume":"39","author":"MM Davidson","year":"2005","unstructured":"Davidson, M. M. et al. Novel cell lines derived from adult human ventricular cardiomyocytes. J. Mol. Cell. Cardiol. 39, 133\u2013147 (2005).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"827_CR34","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1079\/IVP2006787","volume":"42","author":"BI Goldman","year":"2006","unstructured":"Goldman, B. I., Amin, K. M., Kubo, H., Singhal, A. & Wurzel, J. Human myocardial cell lines generated with SV40 temperature-sensitive mutant tsA58. In Vitro Cell. Dev. Biol. Anim. 42, 324\u2013331 (2006).","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"827_CR35","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.stemcr.2017.10.024","volume":"9","author":"V Schwach","year":"2017","unstructured":"Schwach, V. et al. A COUP-TFII human embryonic stem cell reporter line to identify and select atrial cardiomyocytes. Stem Cell Rep. 9, 1765\u20131779 (2017).","journal-title":"Stem Cell Rep."},{"key":"827_CR36","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.7150\/thno.19427","volume":"7","author":"K Ban","year":"2017","unstructured":"Ban, K., Bae, S. & Yoon, Y. S. Current strategies and challenges for purification of cardiomyocytes derived from human pluripotent stem cells. Theranostics 7, 2067\u20132077 (2017).","journal-title":"Theranostics"},{"key":"827_CR37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.stem.2017.07.003","volume":"21","author":"JH Lee","year":"2017","unstructured":"Lee, J. H., Protze, S. I., Laksman, Z., Backx, P. H. & Keller, G. M. Human pluripotent stem cell-derived atrial and ventricular cardiomyocytes develop from distinct mesoderm populations. Cell Stem Cell 21, 179\u2013194.e4 (2017).","journal-title":"Cell Stem Cell"},{"key":"827_CR38","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/j.stemcr.2018.04.005","volume":"10","author":"M Argenziano","year":"2018","unstructured":"Argenziano, M. et al. Electrophysiologic characterization of calcium handling in human induced pluripotent stem cell-derived atrial cardiomyocytes. Stem Cell Rep. 10, 1867\u20131878 (2018).","journal-title":"Stem Cell Rep."},{"key":"827_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45047-9","volume":"9","author":"MA Branco","year":"2019","unstructured":"Branco, M. A. et al. Transcriptomic analysis of 3D cardiac differentiation of human induced pluripotent stem cells reveals faster cardiomyocyte maturation compared to 2D culture. Sci. Rep. 9, 9229 (2019).","journal-title":"Sci. Rep."},{"key":"827_CR40","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.stem.2020.06.001","volume":"27","author":"JW Buikema","year":"2020","unstructured":"Buikema, J. W. et al. Wnt activation and reduced cell-cell contact synergistically induce massive expansion of functional human iPSC-derived cardiomyocytes. Cell Stem Cell 27, 50\u201363.e5 (2020).","journal-title":"Cell Stem Cell"},{"key":"827_CR41","doi-asserted-by":"publisher","first-page":"394","DOI":"10.15252\/emmm.201404757","volume":"7","author":"HD Devalla","year":"2015","unstructured":"Devalla, H. D. et al. Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology. EMBO Mol. Med. 7, 394\u2013410 (2015).","journal-title":"EMBO Mol. Med."},{"key":"827_CR42","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1161\/CIRCULATIONAHA.111.067306","volume":"125","author":"N Voigt","year":"2012","unstructured":"Voigt, N. et al. Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation. Circulation 125, 2059\u20132070 (2012).","journal-title":"Circulation"},{"key":"827_CR43","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1161\/CIRCULATIONAHA.113.006641","volume":"129","author":"N Voigt","year":"2014","unstructured":"Voigt, N. et al. Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation. Circulation 129, 145\u2013156 (2014).","journal-title":"Circulation"},{"key":"827_CR44","doi-asserted-by":"publisher","unstructured":"Heijman, J. et al. Atrial myocyte NLRP3\/CaMKII nexus forms a substrate for post-operative atrial fibrillation. Circ. Res. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.316710 (2020).","DOI":"10.1161\/CIRCRESAHA.120.316710"},{"key":"827_CR45","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3389\/fphys.2019.00818","volume":"10","author":"H Nakanishi","year":"2019","unstructured":"Nakanishi, H. et al. Geometrical patterning and constituent cell heterogeneity facilitate electrical conduction disturbances in a human induced pluripotent stem cell-based platform: an in vitro disease model of atrial arrhythmias. Front. Physiol. 10, 818 (2019).","journal-title":"Front. Physiol."},{"key":"827_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13868-x","volume":"11","author":"I Goldfracht","year":"2020","unstructured":"Goldfracht, I. et al. Generating ring-shaped engineered heart tissues from ventricular and atrial human pluripotent stem cell-derived cardiomyocytes. Nat. Commun. 11, 75 (2020).","journal-title":"Nat. Commun."},{"key":"827_CR47","first-page":"E25","volume":"87","author":"D Harrild","year":"2000","unstructured":"Harrild, D. & Henriquez, C. A computer model of normal conduction in the human atria. Circ. Res. 87, E25\u2013E36 (2000).","journal-title":"Circ. Res."},{"key":"827_CR48","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.pbiomolbio.2007.03.014","volume":"94","author":"M Valderrabano","year":"2007","unstructured":"Valderrabano, M. Influence of anisotropic conduction properties in the propagation of the cardiac action potential. Prog. Biophys. Mol. Biol. 94, 144\u2013168 (2007).","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"827_CR49","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1111\/bph.13807","volume":"175","author":"SC Salvage","year":"2018","unstructured":"Salvage, S. C. et al. Multiple targets for flecainide action: implications for cardiac arrhythmogenesis. Br. J. Pharmacol. 175, 1260\u20131278 (2018).","journal-title":"Br. J. Pharmacol."},{"key":"827_CR50","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.stemcr.2018.10.008","volume":"11","author":"M Lemme","year":"2018","unstructured":"Lemme, M. et al. Atrial-like engineered heart tissue: an in vitro model of the human atrium. Stem Cell Rep. 11, 1378\u20131390 (2018).","journal-title":"Stem Cell Rep."},{"key":"827_CR51","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.cell.2018.11.042","volume":"176","author":"Y Zhao","year":"2019","unstructured":"Zhao, Y. et al. A platform for generation of chamber-specific cardiac tissues and disease modeling. Cell 176, 913\u2013927.e18 (2019).","journal-title":"Cell"},{"key":"827_CR52","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1126\/science.aav9051","volume":"365","author":"A Lee","year":"2019","unstructured":"Lee, A. et al. 3D bioprinting of collagen to rebuild components of the human heart. Science 365, 482\u2013487 (2019).","journal-title":"Science"},{"key":"827_CR53","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3389\/fphys.2019.01049","volume":"10","author":"H Yu","year":"2019","unstructured":"Yu, H. & Wang, Z. Cardiomyocyte-derived exosomes: biological functions and potential therapeutic implications. Front. Physiol. 10, 1049 (2019).","journal-title":"Front. Physiol."},{"key":"827_CR54","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1038\/sj.onc.1201196","volume":"14","author":"TH Chang","year":"1997","unstructured":"Chang, T. H., Ray, F. A., Thompson, D. A. & Schlegel, R. Disregulation of mitotic checkpoints and regulatory proteins following acute expression of SV40 large T antigen in diploid human cells. Oncogene 14, 2383\u20132393 (1997).","journal-title":"Oncogene"},{"key":"827_CR55","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1016\/j.hrthm.2016.05.028","volume":"14","author":"A Goette","year":"2017","unstructured":"Goette, A. et al. EHRA\/HRS\/APHRS\/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. Heart Rhythm 14, e3\u2013e40 (2017).","journal-title":"Heart Rhythm"},{"key":"827_CR56","first-page":"379","volume":"7","author":"RB DuBridge","year":"1987","unstructured":"DuBridge, R. B. et al. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7, 379\u2013387 (1987).","journal-title":"Mol. Cell. Biol."},{"key":"827_CR57","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884\u2013i890 (2018).","journal-title":"Bioinformatics"},{"key":"827_CR58","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417\u2013419 (2017).","journal-title":"Nat. Methods"},{"key":"827_CR59","doi-asserted-by":"publisher","first-page":"e1007664","DOI":"10.1371\/journal.pcbi.1007664","volume":"16","author":"MI Love","year":"2020","unstructured":"Love, M. I. et al. Tximeta: reference sequence checksums for provenance identification in RNA-seq. PLoS Comput. Biol. 16, e1007664 (2020).","journal-title":"PLoS Comput. Biol."},{"key":"827_CR60","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902.e21 (2019).","journal-title":"Cell"},{"key":"827_CR61","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"827_CR62","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.celrep.2015.09.025","volume":"13","author":"MJ Birket","year":"2015","unstructured":"Birket, M. J. et al. Contractile defect caused by mutation in MYBPC3 revealed under conditions optimized for human PSC-cardiomyocyte function. Cell Rep. 13, 733\u2013745 (2015).","journal-title":"Cell Rep."},{"key":"827_CR63","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/BF01870526","volume":"121","author":"PH Barry","year":"1991","unstructured":"Barry, P. H. & Lynch, J. W. Liquid junction potentials and small cell effects in patch-clamp analysis. J. Membr. Biol. 121, 101\u2013117 (1991).","journal-title":"J. Membr. Biol."},{"key":"827_CR64","doi-asserted-by":"publisher","first-page":"649414","DOI":"10.3389\/fphar.2021.649414","volume":"12","author":"AO Verkerk","year":"2021","unstructured":"Verkerk, A. O. et al. Patch-clamp recordings of action potentials from human atrial myocytes: optimization through dynamic clamp. Front. Pharmacol. 12, 649414 (2021).","journal-title":"Front. Pharmacol."},{"key":"827_CR65","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s10557-019-06925-6","volume":"33","author":"S Casini","year":"2019","unstructured":"Casini, S. et al. Absence of functional Nav1.8 channels in non-diseased atrial and ventricular cardiomyocytes. Cardiovasc. Drugs Ther. 33, 649\u2013660 (2019).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"827_CR66","doi-asserted-by":"publisher","first-page":"752","DOI":"10.2459\/JCM.0000000000000868","volume":"20","author":"NWE van den Berg","year":"2019","unstructured":"van den Berg, N. W. E. et al. PREventive left atrial appenDage resection for the predICtion of fuTure atrial fibrillation: design of the PREDICT AF study. J. Cardiovasc. Med. 20, 752\u2013761 (2019).","journal-title":"J. Cardiovasc. Med."}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-021-00827-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-021-00827-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-021-00827-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T09:19:55Z","timestamp":1669281595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-021-00827-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,6]]},"references-count":66,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["827"],"URL":"https:\/\/doi.org\/10.1038\/s41551-021-00827-5","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.741558421.793596392","asserted-by":"object"}]},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,6]]},"assertion":[{"value":"20 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.J.S., D.A.P. and A.A.F.d.V. are inventors of a patent application (US16\/480,280, \u2018Conditionally immortalized cells and methods for their preparation\u2019) related to this work. R.P. is a cofounder of Pluriomics (Ncardia) and River Biomedics. D.D. is a member of the scientific advisory boards of OMEICOS Therapeutics and Acesion Pharma. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}